A new COVID-19 subvariant is quietly making its way around the world, and health officials are paying close attention. Known as BA.3.2 and nicknamed the “Cicada” variant, the strain belongs to the Omicron family of the SARS-CoV-2 virus and has now been detected in at least 23 countries. The World Health Organization is currently tracking it as a variant under monitoring, meaning it is being observed carefully but is not yet considered a significant public health threat.
The “Cicada” nickname stems from the variant’s behavior — it tends to resurface after periods of low activity, much like the insect it is named after.
The 6 symptoms linked to the Cicada variant
For most people, particularly those who are vaccinated, symptoms associated with BA.3.2 are expected to be mild to moderate. Reported cases have largely mirrored those seen with earlier Omicron strains. The six most commonly noted symptoms are: 1) sore throat, 2) persistent cough, 3) fever and chills, 4) fatigue, 5) runny or blocked nose and 6) headache and muscle aches.
Anyone experiencing a combination of these symptoms is encouraged to test and stay home to avoid further spread.
Why health experts are keeping a close eye on it
The primary reason BA.3.2 has drawn scientific attention is its mutation profile. The variant carries a notably high number of changes in its spike protein, which could potentially affect how easily it spreads or how well the immune system recognizes it.
That said, there is currently no evidence to suggest that BA.3.2 causes more severe illness than previous Omicron variants. Hospitalizations and deaths linked specifically to this strain have not shown alarming patterns at this stage, which is an encouraging sign as researchers continue their analysis.
Are existing vaccines still effective?
The short answer is yes. Current vaccines are still expected to offer strong protection against severe disease, hospitalization and death, even with this newer variant in circulation. Some degree of immune escape is possible, meaning breakthrough infections can still occur in vaccinated individuals, but the likelihood of serious complications remains significantly lower for those who are up to date on their shots.
Booster doses continue to be an important tool in maintaining immunity, especially as the virus evolves. Health authorities continue to recommend staying current with available boosters where eligible.
Should you be worried?
Experts are not sounding the alarm just yet. The consensus remains that awareness, rather than panic, is the appropriate response at this point. BA.3.2 is being monitored as a precaution, and its real-world impact is still being assessed. However, its mutation pattern means it warrants attention, particularly in regions where case counts begin to climb.
What you can do right now
Standard COVID-19 precautions remain the most reliable line of defense against BA.3.2 as they have been against previous strains. Practicing good hand hygiene, wearing a mask in crowded or enclosed spaces, staying home when feeling unwell and testing when symptoms appear are all still effective measures.
The emergence of the Cicada variant is a reminder that COVID-19 continues to evolve, even as the world has largely moved on from the acute phase of the pandemic. Staying informed and taking basic precautions remains the smartest approach as scientists work to better understand this latest development in the ongoing story of SARS-CoV-2.
Source: Mashable India
